Validation of the CULTEX® Radial Flow System for the assessment of the acute inhalation toxicity of airborne particles.


Journal

Toxicology in vitro : an international journal published in association with BIBRA
ISSN: 1879-3177
Titre abrégé: Toxicol In Vitro
Pays: England
ID NLM: 8712158

Informations de publication

Date de publication:
Aug 2019
Historique:
received: 10 12 2018
revised: 08 03 2019
accepted: 15 03 2019
pubmed: 21 3 2019
medline: 4 12 2019
entrez: 21 3 2019
Statut: ppublish

Résumé

The CULTEX® Radial Flow System (RFS) is a modular in vitro system for the homogenous exposure of cells to airborne particles at the air-liquid interface (ALI). A former pre-validation study successfully demonstrated the general applicability of the CULTEX® RFS and its transferability, stability and reproducibility. Based on these results, the methodology was optimized, validated and prediction models for acute inhalation hazards were established. Cell viability of A549 cells after ALI exposure to 20 pre-selected test substances was assessed in three independent laboratories. Cytotoxicity of test substances was compared to the respective incubator controls and used as an indicator of toxicity. Substances were considered to exert an acute inhalation hazard when viability decreased below 50% (prediction model (PM) 50%) or 75% (PM 75%) at any of three exposure doses (25, 50 or 100 μg/cm

Identifiants

pubmed: 30890356
pii: S0887-2333(18)30811-7
doi: 10.1016/j.tiv.2019.03.020
pii:
doi:

Substances chimiques

Air Pollutants 0
Particulate Matter 0

Types de publication

Journal Article Validation Study

Langues

eng

Sous-ensembles de citation

IM

Pagination

245-255

Informations de copyright

Copyright © 2019 Elsevier Ltd. All rights reserved.

Auteurs

Amelie Tsoutsoulopoulos (A)

Bundeswehr Institute of Pharmacology and Toxicology, Munich, Germany. Electronic address: amelie1tsoutsoulopoulos@bundeswehr.org.

Katrin Gohlsch (K)

Walther-Straub-Institute of Pharmacology and Toxicology, Ludwig-Maximilians-Universität, Munich, Germany.

Niklas Möhle (N)

Cultex® Laboratories GmbH, Hannover, Germany.

Andreas Breit (A)

Walther-Straub-Institute of Pharmacology and Toxicology, Ludwig-Maximilians-Universität, Munich, Germany.

Sebastian Hoffmann (S)

seh consulting + services, Paderborn, Germany.

Olaf Krischenowski (O)

Cultex® Laboratories GmbH, Hannover, Germany; Cultex® Technology GmbH (formerly Cultex® Laboratories GmbH), Hannover, Germany.

Harald Mückter (H)

Walther-Straub-Institute of Pharmacology and Toxicology, Ludwig-Maximilians-Universität, Munich, Germany.

Thomas Gudermann (T)

Walther-Straub-Institute of Pharmacology and Toxicology, Ludwig-Maximilians-Universität, Munich, Germany.

Horst Thiermann (H)

Bundeswehr Institute of Pharmacology and Toxicology, Munich, Germany.

Michaela Aufderheide (M)

Cultex® Laboratories GmbH, Hannover, Germany; Cultex® Technology GmbH (formerly Cultex® Laboratories GmbH), Hannover, Germany.

Dirk Steinritz (D)

Bundeswehr Institute of Pharmacology and Toxicology, Munich, Germany; Walther-Straub-Institute of Pharmacology and Toxicology, Ludwig-Maximilians-Universität, Munich, Germany.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH